401(k) losses in Andrew Left trial highlight market risks

401(k) losses – A retired firefighter testified he lost most of his 401(k) after investing in stocks criticized by Andrew Left, as prosecutors continue their case in Los Angeles.

A retired firefighter’s testimony at Andrew Left’s securities fraud trial brought the stakes of Wall Street commentary down to a family’s retirement account, with the witness describing steep losses after following investments tied to the short-seller’s public remarks.

Billy Banks, a retired firefighter from Texas, testified in a Los Angeles federal court on Thursday.. Prosecutors said the case involves how Andrew Left. the founder of Citron Research and a frequent presence on financial television. allegedly used his public profile to influence markets while deceiving retail investors.

Banks told the court that in 2018, while working as a firefighter, he became more active in his investing.. He said he moved roughly $110. 000 from mutual funds in his 401(k) into shares of a cannabis company called CV Sciences. trading under the ticker CVSI. after concluding the business had strong CBD products that “really helped” with stress and pain management.

He described the emotional swing that followed. While on vacation with his wife, Banks said he checked the value of his investment and saw it rise from about $110,000 to around $190,000. He told the court he felt immediate excitement, likening it to tending something that had begun to grow.

Banks said the turning point came shortly after he returned from vacation, when Left made negative comments about CV Sciences. He testified that the stock price then fell sharply, and that although he still believed in the products, he couldn’t justify the “beatdown” as the decline continued.

According to Banks, he ultimately sold his CVSI shares, losing around $80,000 of his initial investment. He testified that he then took about $30,000 of remaining funds and moved into another cannabis stock, investing in a company called Namaste.

Banks told jurors that his decision to buy Namaste was influenced by a TV appearance in which Left said he believed the company’s shares would go to zero. Banks said the prospect of such a collapse felt like his money was moving toward disaster, and he described his reaction as horror.

When he sold his Namaste position, Banks said he had lost around 80% of the investment. He called the outcome “devastating,” presenting the losses as the result of a series of market moves that followed the short-seller’s public statements.

The defense told the jury that Left never recommended anyone buy CV Sciences or Namaste.. It also argued that Left’s negative view on Namaste proved to be accurate. and that if Banks had sold all his shares at the time Left issued the negative report. he would have lost less money than he did after waiting.

Prosecutors called another retail investor on Thursday as well.. Adam Gray. who said he was working as a car salesman in South Dakota in 2018. described how he began trading and learning about stocks and said he followed Left for perspective.. Over time, Gray testified that he became concerned that Left’s behavior was potentially fraudulent.

Gray said he was closely watching cannabis stocks and believed Left was taking a long position in one cannabis company while sharing negative information about two competitors.. He told the court that the pattern “seemed off. ” explaining that such a combination felt inconsistent with how information is typically used in markets.

Gray testified that he later sent a tip to the Securities and Exchange Commission. The court heard that it is unclear whether that tip sparked the investigation into Left, but the testimony positioned Gray as part of the retail trading audience prosecutors say was targeted.

As the trial continues, the defense maintained that its reports about the cannabis companies Left criticized were accurate. The proceedings are set to move forward on Friday.

For retail investors. Banks’ testimony underscores a risk that can be difficult to quantify in advance: the speed at which public commentary can change stock prices. especially in sectors where investor sentiment can swing quickly.. Even when a buyer believes in a product. market reactions can turn a thesis into a loss if the price moves faster than fundamentals can be reassessed.

The case also highlights how retirement accounts can concentrate exposure.. Banks described transferring money out of mutual funds into individual stocks within a 401(k). a choice that typically increases both potential returns and volatility compared with diversified holdings.. In that framework. sharp declines can have immediate consequences because the investor’s capital is no longer spread across a broad set of assets.

Prosecutors’ theory. as presented through witness testimony. revolves around more than whether a stock falls—it is about how information was used and who it benefited.. Whether the defense’s argument persuades jurors may depend on how they view the difference between investment commentary that proves correct in hindsight and the claim that the commentary was allegedly used to mislead and manipulate.

The trial also draws a line between retail perception and regulatory scrutiny. Gray’s testimony showed how an investor’s interpretation of signals—such as the pairing of long bets in one name with critical remarks about others—can lead to escalation, including reporting to regulators.

Meanwhile. the courtroom descriptions of CV Sciences and Namaste reflect how tightly retail traders can link decisions to recognizable figures in finance.. The tension at the heart of the trial is whether that influence amounted to deception. or whether investors simply acted on views that later proved right or wrong.

As Friday’s testimony approaches, the central questions remain grounded in the details already offered: what was said, when it was said, and how the resulting market moves were experienced by the investors who put their retirement savings on the line.

Andrew Left trial 401(k) losses Citron Research retail investor securities fraud case cannabis stocks SEC tip